Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Edwards Lifesciences Corp Director's Dealing 2012

Jul 31, 2012

30042_dirs_2012-07-31_df6d6637-328f-426a-80c6-32038c75eaf9.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Edwards Lifesciences Corp (EW)
CIK: 0001099800
Period of Report: 2012-07-27

Reporting Person: WANG HUIMIN (CVP, Japan & Intercontinental)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-07-27 Common Stock S 2404.0000 $102.7900 Disposed 47167.1278 Direct

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $102.78 to $102.79. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F2: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person.